Dynabeads™ MyOne™ Streptavidin T1
Dynabeads™ MyOne™ Streptavidin T1
Invitrogen™

Dynabeads™ MyOne™ Streptavidin T1

Dynabeads MyOne Streptavidin T1은 바이오티닐화 핵산, 항체 또는 기타 바이오티닐화 리간드 및 타겟의 분리와 취급에 사용되는 gold standard입니다. streptavidin-biotin 상호작용의자세히 알아보기
Have Questions?
보기 방식 변경buttonViewtableView
카탈로그 번호제품 유형수량
65305Dynabeads™ M-270 Streptavidin2 mL
65001Dynabeads™ MyOne™ Streptavidin C12 mL
65002Dynabeads™ MyOne™ Streptavidin C110 mL
65604DDynabeads™ MyOne™ Streptavidin T150 mL
65602Dynabeads™ MyOne™ Streptavidin T110 mL
65601Dynabeads™ MyOne™ Streptavidin T12 mL
65605DDynabeads™ Streptavidin for Target Enrichment2 mL
65606DDynabeads™ Streptavidin for Target Enrichment10 mL
65607DDynabeads™ Streptavidin for Target Enrichment50 mL
11205DDynabeads™ M-280 Streptavidin2 mL
11206DDynabeads™ M-280 Streptavidin10 mL
60210Dynabeads™ M-280 Streptavidin100 mL
65306Dynabeads™ M-270 Streptavidin10 mL
60101Dynabeads™ kilobaseBINDER™ Kit200 Isolations
65801DDynabeads™ Streptavidin Trial Kit4 x 1 mL
카탈로그 번호 65305
제품 가격(KRW)
785,000
온라인 행사
Ends: 31-Dec-2025
872,000
할인액 87,000 (10%)
Each
카트에 추가하기
제품 유형:
Dynabeads™ M-270 Streptavidin
수량:
2 mL
제품 가격(KRW)
785,000
온라인 행사
Ends: 31-Dec-2025
872,000
할인액 87,000 (10%)
Each
카트에 추가하기

Dynabeads MyOne Streptavidin T1은 바이오티닐화 핵산, 항체 또는 기타 바이오티닐화 리간드 및 타겟의 분리와 취급에 사용되는 gold standard입니다. streptavidin-biotin 상호작용의 매우 높은 결합 친화도(Kd=10-15)는 수 많은 응용 분야에 사용됩니다. 장점 및 특징:

• 모든 바이오티닐화 분자의 직접 및 빠른 분리
• 부드럽고 효율적인 액상 반응 kinetics로 유연한 프로토콜
• 단백질, 펩타이드, 항체의 결합에 최적화된 low-charged 및 neutral 비드
• 크기가 작지만 균일하여 mg 비드당 표면적이 크고, 따라서 표적 분자에 대한 용량이 높음
• 낮은 침강 속도와 높은 철 함량을 바탕으로 빠른 마그네틱 분리가 가능함
• 바이오마그네틱(biomagnetic) 프로토콜은 자동화 플랫폼에 쉽게 적용 가능
• 높은 배치 간(batch-to-batch) 재현성으로 응용 분야에서 일관된 결과 보장

Dynabeads MyOne Streptavidin T1 정보
이 독특한 초상자성 비드는 지름이 1 µm이며, 다중 층이 아닌 단층의 재조합 스트렙타비딘(streptavidin)이 표면에 공유 결합되어 있으며 BSA로 블락되어 있습니다. 이 단층의 스트렙타비딘은 자유 비오틴 뿐만 아니라 바이오티닐화 리간드/타겟의 결합에도 이용가능한 입체적인 비오틴 결합 부위가 많이 있습니다. 이 비드는 빠른 액상 반응 속도를 보여줍니다. 이 비드의 특이적으로 정의된 표면은 효율적인 캡쳐, 분리, 다운스트림 핸들링( downstream handling)을 가능하게 합니다. 단층의 스트렙타비딘은 누출이 거의 없고 과도하게 흡수되는 스트렙타비딘이 없어 배치(batch) 일관성과 결과의 재현성을 보장합니다. 1 µm Dynabeads MyOne은 넓은 표면적, 고용량, 효율적인 마그네틱 끌어당김(magnetic pull), 인큐베이션 중 느린 침강 속도 등의 특징이 있습니다. 고처리량(High throughput)이 중요한 경우에는 자동화된 프로토콜을 사용하여 맞춤화가 가능합니다.

응용 분야
지난 15년 동안 streptavidin-coupled Dynabeads는 매우 다양한 응용 분야에 사용되어 왔습니다. 주요 응용 분야로는 단일 가닥 DNA 템플릿 준비, RNA 및 DNA 결합 단백질 분리, 큰 DNA fragment 고정, 시퀀싱(sequencing) 산물 정제, 특이적 핵산 캡쳐 등이 있습니다. 이 비드는 자동 프로세스에 쉽게 적용됩니다. Dynabeads는 전 세계에서 25,000개 이상의 일상적인 IVD 기기에 사용되고 있습니다.

결합 용량
분자의 크기와 바이오티닐화 절차는 결합 능력에 영향을 미칩니다. 이 결합 용량은 입체적 가용성(steric availability), 비드와 분자간 및 분자들 간의 전하 상호작용에 따라 달라집니다. 고정화 후 비드 표면 상에서 이용가능한 비오틴 결합 부위는 스트렙타비딘 분자당 2개 또는 3개입니다. 1 mg의 Dynabeads MyOne Streptavidin T1은 일반적으로 다음과 결합합니다.

• 950–1500 pmoles 자유 비오틴
• ∼20µg 바이오티닐화 IgG
• ∼400 pmol 바이오티닐화 펩타이드
• ∼20µg ds-DNA
• ∼400 pmol ss-올리고뉴클레오티드

연구용으로만 사용하십시오. 진단용으로는 사용할 수 없습니다.
사양
비드 유형Magnetic polystyrene-based beads covalently coupled with recombinant Streptavidin
결합 특성≥950 pmol free biotin/mg beads
인증/적합성ISO9001 and ISO13485
농도10 mg/mL
직경(미터법)2.8 μm (CV < 5%)
용도(애플리케이션)Aggregation-prone immunoassays, immunoprecipitations, or DNA/RNA isolation followed by enzymatic reactions, requiring high specificity, ease of handling under harsh conditions, and minimal nuclease activity
용도(장비)KingFisher™ Sample Purification System, DynaMag™ magnets
고처리량 호환성High-throughput Compatible
제품라인Dynabeads
제품 유형Dynabeads™ M-270 Streptavidin
수량2 mL
규제 상태For Research Use Only
유통 기한36 months from date of manufacture
배송 조건Ambient Temperature
표면 기능성Carboxylic acid hydrophilic surface, non-blocked
형식Beads in Suspension
Isolation TechnologyMagnetic Bead
Unit SizeEach
구성 및 보관
Dynabeads M-270 Streptavidin is supplied in PBS, pH 7.4 with 0.02% NaN3. Store at 2°C to 8°C.

자주 묻는 질문(FAQ)

Can Dynabeads Streptavidin magnetic beads be boiled?

We do not recommend this as streptavidin becomes hydrophobic and aggregates during denaturation.

I am getting high background using Dynabeads M-280 Streptavidin magnetic beads. How can I prevent this from happening?

The background might be caused by nonspecific binding to the BSA on the bead surface. Alternatively, high background might be caused by nonspecific binding to streptavidin. Increasing either the pH or the salt concentration might help reduce the binding. Dynabeads M-270 Streptavidin magnetic beads might be a better alternative; these beads are not coated with BSA and are hydrophilic, as they are based upon carboxylic acid chemistry.

My Dynabeads magnetic beads are not pelleting well with the magnet. Do you have any suggestions for me?

Please review the following possibilities for why your Dynabeads magnetic beads are not pelleting:

- The solution is too viscous.
- The beads have formed aggregates because of protein-protein interaction.

Try these suggestions: - Increase separation time (leave tub on magnet for 2-5 minutes)
- Add DNase I to the lysate (~0.01 mg/mL)
- Increase the Tween 20 concentration to ~0.05% of the binding and/or washing buffer.
- Add up to 20 mM beta-merecaptoethanol to the binding and/or wash buffers.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

Which streptavidin-conjugated Dynabeads magnetic beads are the right beads for my application?

Which product to choose depends on the properties of your sample, the buffers and solutions applied, as well as the downstream application. In general, all Dynabeads Streptavidin beads can be used in applications involving biotinylated ligands; however, some beads may perform better than others in particular applications due to their characteristics. Dynabeads M-280 Streptavidin beads and Dynabeads MyOne Streptavidin T1 beads are commonly used for protein and nucleic acid applications. Dynabeads M-270 Streptavidin beads and MyOne Streptavidin C1 beads are preferred for nucleic acid diagnostics, specifically with samples that have a high concentration of chaotropic salts, immunoassays involving small biotinylated antigens, and in applications that are not compatible with BSA, as these beads are not blocked with BSA. Dynabeads MyOne Streptavidin beads offer increased binding capacity and slower sedimentation rate, making them ideal for automated applications and when larger amounts of a biotinylated compound or its specific target need to be isolated. Please see the selection guide here ( https://www.thermofisher.com/us/en/home/brands/product-brand/dynal/streptavidin-coupled-dynabeads.html?icid=fr-strep-1).

How do I measure the binding of biotinylated nucleic acid on streptavidin beads?

You can assay the supernatant for unbound nucleic acid to determine the amount of nucleic acid bound to the Dynabeads Streptavidin beads. The concentration of nucleic acids can be checked by measuring the OD or by running them on a gel. Alternatively, the nucleic acids can be labeled radioactively and the concentration measured directly on the beads, or fluorescently and measured in the supernatant.

인용 및 참조 문헌 (4)

인용 및 참조 문헌
Abstract
Quantum-dot-assisted characterization of microtubule rotations during cargo transport.
Authors:Nitzsche B, Ruhnow F, Diez S,
Journal:Nat Nanotechnol
PubMed ID:18772917
Owing to their wide spectrum of in vivo functions, motor proteins, such as kinesin-1, show great potential for application as nanomachines in engineered environments. When attached to a substrate surface, these motors are envisioned to shuttle cargo that is bound to reconstituted microtubules--one component of the cell cytoskeleton--from one location ... More
Sialic Acids Attached to O-Glycans Modulate Voltage-gated Potassium Channel Gating.
Authors:Schwetz TA, Norring SA, Ednie AR, Bennett ES,
Journal:J Biol Chem
PubMed ID:21115483
Neuronal, cardiac, and skeletal muscle action potentials are produced and conducted through the highly regulated activity of several types of voltage-gated ion channels. Voltage-gated potassium (K(v)) channels are responsible for action potential repolarization. Glycans can be attached to glycoproteins through N- and O-linkages. Previous reports described the impact of N-glycans ... More
A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy.
Authors:Wuest SC, Edwan JH, Martin JF, Han S, Perry JS, Cartagena CM, Matsuura E, Maric D, Waldmann TA, Bielekova B
Journal:Nat Med
PubMed ID:21532597
Although previous studies have described CD25 expression and production of interleukin-2 (IL-2) by mature dendritic cells (mDCs), it remains unclear how these molecules participate in the activation of T cells. In search of the mechanisms by which daclizumab, a humanized monoclonal antibody against CD25, inhibits brain inflammation in multiple sclerosis, ... More
Development of Phage-Based Antibody Fragment Reagents for Affinity Enrichment of Bacterial Immunoglobulin G Binding Proteins.
Authors:Säll A, Sjöholm K, Waldemarson S, Happonen L, Karlsson C, Persson H, Malmström J
Journal:
PubMed ID:26452057
Disease and death caused by bacterial infections are global health problems. Effective bacterial strategies are required to promote survival and proliferation within a human host, and it is important to explore how this adaption occurs. However, the detection and quantification of bacterial virulence factors in complex biological samples are technically ... More